Ionis Pharmaceuticals, Inc.
(NASDAQ : IONS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.30%171.891.3%$501.59m
BIIBBiogen Inc.
1.59%236.631.3%$486.91m
CELGCelgene Corporation
0.22%96.461.3%$469.64m
GILDGilead Sciences, Inc.
0.14%66.610.9%$452.76m
ILMNIllumina, Inc.
2.26%313.413.5%$316.81m
REGNRegeneron Pharmaceuticals, Inc.
3.11%319.582.6%$293.34m
AAgilent Technologies, Inc.
-0.16%68.211.6%$199.63m
VRTXVertex Pharmaceuticals Incorporated
2.87%173.981.9%$182.69m
EXASExact Sciences Corporation
-1.34%95.6525.3%$168.53m
ALXNAlexion Pharmaceuticals, Inc.
-0.26%128.472.0%$151.06m
BMRNBioMarin Pharmaceutical Inc.
0.58%87.984.3%$118.39m
SRPTSarepta Therapeutics, Inc.
0.93%122.3214.7%$116.56m
INCYIncyte Corporation
0.97%79.442.5%$107.78m
IONSIonis Pharmaceuticals, Inc.
-0.79%68.708.2%$98.58m
ALNYAlnylam Pharmaceuticals, Inc
1.08%68.609.2%$96.64m

Company Profile

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.